In yesterday’s Wall Street session, Fate Therapeutics Inc (NASDAQ:FATE) shares traded at $3.87, down -10.00% from the previous session.
FATE stock price is now -42.73% away from the 50-day moving average and -5.24% away from the 200-day moving average. The market capitalization of the company currently stands at $440.48M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
On January 24, 2023, H.C. Wainwright Downgraded its previous ‘Buy’ rating to ‘Neutral’ on the stock reducing its target price from $115 to quote $7, while ‘Wedbush’ rates the stock as ‘Neutral’
In other news, Dulac Edward J III, Chief Financial Officer sold 2,447 shares of the company’s stock on Mar 04 ’24. The stock was sold for $19,013 at an average price of $7.77. Upon completion of the transaction, the Chief Financial Officer now directly owns 101,479 shares in the company, valued at $0.39 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Jan 29 ’24, Chief Financial Officer Dulac Edward J III sold 1,849 shares of the business’s stock. A total of $9,245 was realized by selling the stock at an average price of $5.00. This leaves the insider owning 103,926 shares of the company worth $0.4 million. A total of 12.59% of the company’s stock is owned by insiders.
During the past 12 months, Fate Therapeutics Inc has had a low of $1.63 and a high of $8.83. As of last week, the company has a debt-to-equity ratio of 0.28, a current ratio of 8.48, and a quick ratio of 8.48.
According to the Biotechnology Company, earnings per share came in at -0.19, beating analysts’ expectations of -0.62 by 0.43. This compares to -$0.58 EPS in the same period last year. The net profit margin was -253.30% and return on equity was -37.76% for FATE. The company reported revenue of $1.68 million for the quarter, compared to $44.36 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -96.22 percent. For the current quarter, analysts expect FATE to generate $1.11M in revenue.
